Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)-Reference-Cited by-同舟云学术

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)

Published:2016-02-19 Issue:2 Volume:64 Page:360-369
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Lawitz Eric¹,Matusow Gary²,DeJesus Edwin³,Yoshida Eric M.⁴,Felizarta Franco⁵,Ghalib Reem⁶,Godofsky Eliot⁷,Herring Robert W.⁸,Poleynard Gary⁹,Sheikh Aasim¹⁰,Tobias Hillel¹¹,Kugelmas Marcelo¹²,Kalmeijer Ronald¹³,Peeters Monika¹⁴,Lenz Oliver¹⁴,Fevery Bart¹⁴,De La Rosa Guy¹⁵,Scott Jane¹⁶,Sinha Rekha¹³,Witek James¹³

Affiliation:

1. Texas Liver InstituteUniversity of Texas Health Science CenterSan Antonio TX

2. The Gastroenterology Group of South JerseyVineland NJ

3. Orlando Immunology CenterOrlando FL

4. University of British ColumbiaVancouver BC Canada

5. Private practiceBakersfield CA

6. Texas Clinical Research InstituteArlington TX

7. University Hepatitis Center at Pointe West Infectious DiseasesBradenton FL

8. Quality Medical ResearchNashville TN

9. Digestive Health SpecialistsWinston‐Salem NC

10. Gastrointestinal Specialists of GeorgiaMarietta GA

11. Concorde Medical GroupNew York NY

12. South Denver GastroenterologyP.C.Denver CO

13. Janssen Research & Development LLCTitusville NJ

14. Janssen Pharmaceutica NVBeerse Belgium

15. Janssen Global Services LLCTitusville NJ

16. Janssen Global Services LLCHigh Wycombe UK

Funder

Janssen

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.28422

Reference22 articles.

1. Natural history of hepatitis C

2. Treatment of hepatitis C in difficult-to-treat patients

3. European Association for the Study of the Liver.Clinical practice guidelines: recommendations on treatment of hepatitis C 2015.http://www.easl.eu/research/our‐contributions/clinical‐practice‐guidelines/detail/recommendations‐on‐treatment‐of‐hepatitis‐c‐2015. Accessed May 5 2015.

4. American Association for the Study of Liver Diseases.HCV guidance: recommendations for testing managing and treating hepatitis C.www.hcvguidelines.org/full‐report‐view. Accessed May 5 2015.

5. Review of patient-reported outcome measures in chronic hepatitis C

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacophore-Assisted Covalent Docking Identifies a Potential Covalent Inhibitor for Drug-Resistant Genotype 3 Variants of Hepatitis C Viral NS3/4A Serine Protease;Viruses;2024-08-03

2. Therapeutic Intervention of Serine Protease Inhibitors against Hepatitis C Virus;Current Medicinal Chemistry;2023-10-19

3. Comparative Real Life Egyptian Experience of the Combination of Sofosbuvir Plus Daclatasvir or Simeprevir for 12 Weeks in Naïve Cirrhotic Patients Infected with HCV Genotype 4;Current Drug Safety;2023-05

4. Review of heart transplantation from hepatitis C-positive donors;World Journal of Transplantation;2022-12-18

5. The art of managing hepatitis C virus in special population groups: a paradigm shift;Egyptian Liver Journal;2022-11-15